Activity value 79indonesia Buyer&Supplier,Last transaction date:
2026-02-26
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for .pt.etercon pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 2 transactions, with a transaction quantity of 125 and a transaction weight of 0.
5aceto corp
taiwansupplier,they trade on 2021-08-28
254.78%
>
+View All
Products
Total 33
ProductsTransactionsPerDetail
m11 1536.59%>
atorvastatin calcium 1536.59%>
olo 1229.27%>
pvdc coated pvc film 1024.39%>
pvdc 921.95%>
+View All
Hscode rank
Total 54
HSCode NameTransactionsPerDetail
HS 294200901536.59%>
HS 392049001126.83%>
HS 2933210049.76%>
HS 2933599037.32%>
HS 8479904024.88%>
+View All
Trading Area
Total 13
AreaTransactionsPerDetail
india27552.58%>
hong kong15329.25%>
china6211.85%>
singapore101.91%>
other81.53%>
+View All
Port statistics
Total 13
Port NameTransactionsPerDetail
soekarno hatta u14227.15%>
jakarta13225.24%>
tanjung emas12323.52%>
semarang7514.34%>
tanjung priok122.29%>
+View All
.pt.etercon pharma is indonesia Buyer&Supplier,
and primarily engages in the import and export business of products such as m11,atorvastatin calcium,olo.
According to the 52wmb.com global trade database, as of 2026-02-26, the company has completed 594 international trades,
with its main trading regions covering india,hong kong,china etc.
The core products include HS29420090,HS39204900,HS29332100 etc,
often transported via soekarno hatta u,port jakarta, port tanjung emas etc,
and its main trading partners are prohealth management ltd.,aurore life sciences pvt ltd.,alembic pharmaceuticals ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on .pt.etercon pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.